
Senior Supply Chain Analyst optimizing supply chain operations at Amicus Therapeutics. Focusing on data analysis, modeling, and cross - functional collaboration for better supply chain decisions.

We are a global, patient-dedicated biotechnology company focused on discovering, developing, and delivering high-quality medicines for people living with rare metabolic diseases.
Amicus is the Latin word for friend.
This name signifies our collaborative approach to developing medicines by incorporating the patient perspective every step of the way.
Our company was founded by an entrepreneur who embarked on a life-long journey to transform the lives of those living with devastating conditions when two of his children were diagnosed with a rare disease.
That spirit of empathy, compassion, and tenacity permeates our culture and influences all aspects of our approach to advancing cutting-edge technologies.
Building on our core beliefs, our mission-focused behaviors help us define and shape our culture; drive performance and innovation; inform development and growth; and attract, energize, and retain the right talent.
By championing mission-dedication, innovation, performance, and integrity, we are united by our passion for making a difference and committed to pushing ideas as far and as fast as possible.
Our global footprint spans over 20 countries, including our global headquarters in Princeton, NJ and international headquarters in Marlow, UK.
Additional international office locations include Australia, Canada, France, Japan, Germany, Italy, The Netherlands, and Spain.
More information about Amicus and our career opportunities can be found at www.amicusrx.com.
Browse and apply for open jobs at Amicus Therapeutics.

Senior Supply Chain Analyst optimizing supply chain operations at Amicus Therapeutics. Focusing on data analysis, modeling, and cross - functional collaboration for better supply chain decisions.

Executive Director, FP&A for Amicus Therapeutics driving financial support and analytics in global biotech operations. Partnering with R&D and commercial teams on budgets and forecasts.

Vice President of Global Drug Safety at Amicus Therapeutics focusing on rare metabolic diseases and ensuring safety compliance. Driving innovation and high standards in pharmacovigilance and risk management.

Medical Director guiding US strategy for Fabry Disease at Amicus Therapeutics. Leading medical activities and ensuring alignment with global goals in rare disease treatment.

Medical director for US region dedicated to Pompe Disease at Amicus Therapeutics. Leading medical strategy and activities with a focus on therapeutic product development and patient care.

Lead CMC analytical method development, validation, and lifecycle management for large - molecule programs at Amicus Therapeutics. Manage a 3 - 5 person team and represent Analytical Sciences in CMC leadership.

Executive Director Clinical Research at Amicus Therapeutics leading clinical development, protocol design, trial execution, and regulatory submissions for rare metabolic disease therapies.